Dual therapy with remdesivir plus extended nirmatrelvir/ritonavir in immunocompromised and critically ill patient with suspected persistent COVID-19 infection: Case report
Med Intensiva (Engl Ed). 2024 Nov 25:S2173-5727(24)00294-7.
doi: 10.1016/j.medine.2024.11.005.
Online ahead of print.
1 Servicio de Farmacia, Hospital Universitario Reina Sofía, Córdoba, Spain; Instituto Maimones de Investigación Biomédica de Córdoba, (IMIBIC), Córdoba, Spain.